Business Practice

The Alliance for RTU has been founded to accelerate and improve manufacturing quality, consistency, and regulatory efficiency.

Why the traditional model of drug development is no longer fit for purpose.

Sitting Down With… Lars Petersen, President and CEO, FUJIFILM Diosynth Biotechnologies

Biopharma companies procrastinating on sustainability measures risk falling behind, according to Cytiva’ Global Biopharma Sustainability Review.

Civica Rx is approaching generic drug manufacturing using a nonprofit model – and it’s working. We get the story behind their facility in Petersburg.

With open minds and open sources, the future is foundational – and bright.

ADC development is a complex process that can be streamlined – and optimized – by taking the right partnerships and strategies into consideration.

Tips to identify a safe, cost-efficient, and sustainable route to scalable API synthesis

The burden on clinical trials designers and healthcare professionals can only be eased by fixing a broken process: trial feasibility.

Counterfeit deterrents are not yet available in some regions. We speak with Advanco CEO Alf Goebel to find out why.